| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 12/19/2001 | CN1326760A Chinese patent medicine for regulating function of liver and spleen |
| 12/19/2001 | CN1326758A Medicine for curing shaoyang disease and its preparing method |
| 12/19/2001 | CN1326757A Medicinal composition for curing protrusion of lumber intervertebral disc |
| 12/19/2001 | CN1326754A Aloe and ant capsule |
| 12/19/2001 | CN1326749A Insomnic plaster |
| 12/19/2001 | CN1326748A Tincture for curing male's sexual function disturbance and its preparing process |
| 12/19/2001 | CN1326747A Protein iron microelement complement agent and its producing method |
| 12/19/2001 | CN1326746A Montmorilonite as component of animal medicine and fodder additive |
| 12/19/2001 | CN1326745A Montmorillonite as component of gastrointestinal tract medicine |
| 12/19/2001 | CN1326736A Method for preparing heame anti-anemina medicine |
| 12/19/2001 | CN1076202C Prescription of tonglufutanwan as medicine for activating collaterals and rehabilitating paralysis |
| 12/19/2001 | CN1076201C Chinese medicine for treating rheumatoid disease |
| 12/19/2001 | CN1076200C Medicine for curing cardiovascular diseases |
| 12/19/2001 | CN1076193C Chinese medicinal eyedrops |
| 12/18/2001 | US6331658 Genetically engineered mammals for use as organ donors |
| 12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
| 12/18/2001 | US6331609 Fusion protein; for use in treatment of somatotropin defects |
| 12/18/2001 | US6331571 Methods of treating and preventing attention deficit disorders |
| 12/18/2001 | US6331527 Promoter smooth muscle cell expression |
| 12/18/2001 | US6331525 Targeted delivery of genes encoding interferon |
| 12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |
| 12/18/2001 | US6331414 Preparation of human IGF via recombinant DNA technology |
| 12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
| 12/18/2001 | US6331406 Human enbryonic germ cell and methods of use |
| 12/18/2001 | US6331395 Prenatal diagnostic methods |
| 12/18/2001 | US6331319 Implanted to replace or support damaged, diseased tissues or to form cell culture growth substrate |
| 12/13/2001 | WO2001094586A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 12/13/2001 | WO2001094555A1 Method for obtaining characterised muscle-derived cell populations and uses |
| 12/13/2001 | WO2001094553A1 Method of amplifying natural killer t cells |
| 12/13/2001 | WO2001094551A2 Genetically modified t-cells, method for producing them and use thereof |
| 12/13/2001 | WO2001094549A2 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
| 12/13/2001 | WO2001094541A2 Human mesenchymal progenitor cell |
| 12/13/2001 | WO2001094420A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | WO2001093904A1 Method of treating gastrointestinal diseases associated with species of genus clostridium |
| 12/13/2001 | WO2001093901A1 Combined preparation for the treatment of neoplasic diseases |
| 12/13/2001 | WO2001093900A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 12/13/2001 | WO2001093896A2 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs |
| 12/13/2001 | WO2001093895A2 A method of treatment of huntington's chorea with a protein extractable from mammalian organs |
| 12/13/2001 | WO2001093894A2 A method of treatment of parkinson's disease with a protein extractable from mammalian organs |
| 12/13/2001 | WO2001093893A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 12/13/2001 | WO2001093888A2 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs |
| 12/13/2001 | WO2001093882A1 Purified material having size and growth inhibitory effects on cells and tissues |
| 12/13/2001 | WO2001093880A1 Production and use of microvessels in a fibronectin-containing gel |
| 12/13/2001 | WO2001093847A2 Compositions, kits, and methods for promoting defined health benefits |
| 12/13/2001 | WO2001093833A2 Kits and methods for optimizing the efficacy of chondroprotective compositions |
| 12/13/2001 | WO2001093831A2 Low carbohydrate compositions, kits thereof, and methods of use |
| 12/13/2001 | WO2001045735A3 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 12/13/2001 | WO2001043787A3 A process for preparing an autologous platelet gel and membrane thereof |
| 12/13/2001 | WO2001043694A3 Compositions and methods for caspase-induced apoptosis |
| 12/13/2001 | WO2001037881A3 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 12/13/2001 | WO2001027245A3 Generation and characterization of a dendritic cell isolated from human peripheral blood mononuclear cells |
| 12/13/2001 | WO2001026682A3 Modified plant viruses and methods of use thereof |
| 12/13/2001 | WO2001020026A3 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 12/13/2001 | US20010052136 Compositions and methods for producing and using homogenous neuronal cell transplants |
| 12/13/2001 | US20010051834 Method for composite cell-based implants |
| 12/13/2001 | US20010051609 Administering Dna |
| 12/13/2001 | US20010051603 Dried blood factor composition comprising trehalose |
| 12/13/2001 | US20010051595 Injection into blood |
| 12/13/2001 | US20010051375 Highly efficient gene transfer into human repopulating stem cells by RD114 pseudotyped retroviral vector particles |
| 12/13/2001 | US20010051373 T-cell clones expressing anti-hiv-1 factors |
| 12/13/2001 | US20010051162 Use of coxiella bacteria to treat autoimmune disease |
| 12/13/2001 | US20010051152 Somnogenic activity |
| 12/13/2001 | US20010051150 Microencapsulated or enteric coated; therapy for kidney diseases |
| 12/13/2001 | US20010051148 Pretreatment transplantation of organs; genetic engineered culture product |
| 12/13/2001 | DE10062626A1 Cartilage replacement, useful particularly for repairing joint defects, comprises differentiated and proliferating chondrocytes in collagen-based biomatrix |
| 12/13/2001 | DE10062623A1 Cartilage replacement, useful particularly for repairing joint defects, comprises differentiated and proliferating chondrocytes in collagen-based biomatrix |
| 12/13/2001 | DE10027170A1 Humanes PEM als Target für die Fertilitätskontrolle Human PEM as a target for fertility control |
| 12/13/2001 | DE10026789A1 Knorpelersatz und Verfahren zu dessen Herstellung Cartilage replacement and process for its preparation |
| 12/13/2001 | DE10026482A1 Verfahren zur Herstellung eines bioartifiziellen Transplantats A process for the preparation of a bioartificial transplant |
| 12/13/2001 | DE10025609A1 Transfektionssystem Transfection |
| 12/13/2001 | CA2810249A1 Identification and use of human bone marrow-derived endothelial progenitor cell to improve myocardial function after ischemic injury |
| 12/13/2001 | CA2412436A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2411849A1 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
| 12/13/2001 | CA2411762A1 Method for obtaining characterised muscle-derived cell populations and uses |
| 12/13/2001 | CA2411432A1 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs |
| 12/13/2001 | CA2411430A1 A method of treatment of parkinson's disease with a protein extractable from mammalian organs |
| 12/13/2001 | CA2411429A1 A method of treatment of huntington's chorea with a protein extractable from mammalian organs |
| 12/13/2001 | CA2411428A1 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs |
| 12/13/2001 | CA2411285A1 Combined preparation for the treatment of neoplasic diseases |
| 12/13/2001 | CA2410188A1 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 12/13/2001 | CA2409197A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 12/13/2001 | CA2408611A1 Kits and methods for optimizing the efficacy of chondroprotective compositions |
| 12/13/2001 | CA2408610A1 Low carbohydrate compositions, kits thereof, and methods of use |
| 12/13/2001 | CA2408609A1 Compositions, kits, and methods for promoting defined health benefits |
| 12/13/2001 | CA2398277A1 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for protecting cns cells from glutamate toxicity |
| 12/12/2001 | EP1162265A2 Human PEM as a target for fertility control and Alzheimer therapy |
| 12/12/2001 | EP1161955A2 Induction of immunological tolerance for graft transplantation by the use of humanized non-depleting anti-cd4 antibodies in combination with specific donor bone marrow cells |
| 12/12/2001 | EP1161881A2 Method of producing fractions containing a high concentration of milk basic cystatin and decomposition products thereof |
| 12/12/2001 | EP1161549A2 Retrovirus producing cells utilizing a high multiplicity of transduction |
| 12/12/2001 | EP1161523A1 Cells, cell populations, and methods of making and using same |
| 12/12/2001 | EP1161521A2 Transplantation of haematopoietic cells |
| 12/12/2001 | EP1161456A2 Antibody and chemokine constructs and their use for treating autoimmune diseases |
| 12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
| 12/12/2001 | EP1161442A2 Exocytosis pathway proteins and methods of use |
| 12/12/2001 | EP1161251A2 Use of a composition comprising klebsiella pneumoniae proteoglycans, and bacterial ribosomes or ribosomal rna's for treating and/or preventing periodontal diseases |
| 12/12/2001 | EP1161250A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 12/12/2001 | EP1161147A1 Peptide mimics useful for treating disease |
| 12/12/2001 | EP0662088B1 Inhibitor of collagen-stimulated platelet aggregation |